tumour
Targeted chemotherapy to kill all solid tumours developed in preclinical research
August 3, 2023Research and Development Cancer, Oncology, chemotherapy, pharmaceutical, tumour
Researchers from the City of Hope organisation in the US have released a study confirming the development of AOH1996, a …
Bowel cancers adjust themselves to hide from immunotherapies
April 15, 2019Sales and Marketing CEA, Cancer, bowel cancer, immunotherapy, oncology, tumour
Bowel cancers can avoid being caught by immunotherapy by ‘switching off’ a molecule on the surface of cells that is …
Tumours with large number of mutations respond better to immunotherapies, study shows
January 15, 2019Manufacturing and Production, Research and Development Cancer, immunotherapy, nature, oncology, research, tumour
Tumours with a large number of DNA mutations are more likely to respond to immunotherapies than cancers with fewer mutations, …
New ‘pen’ device identifies cancerous tissue in just ten seconds
September 7, 2017Research and Development Cancer, University of Texas, digital, medicine, pharma, pharmaceutical, tumour
Scientists at the Baylor College of Medicine, University of Texas have developed a device which they claim can identify cancerous …
Antiparasitic drug repurposed for treatment of brain tumours
April 13, 2017Research and Development Low-grade glioma, parasitic pinworms, tumour
Researchers from The Feinstein Institute for Medical Research’s Karches Center for Oncology Research has had a research breakthrough by taking …
Foundation Medicine adds new immunotherapy features to its gene profiling products
August 23, 2016Manufacturing and Production, Research and Development FoundationOne, oncology, tumour
Foundation Medicine hopes to enhance oncologist insight into potential immunotherapy responses with the addition of new clinical markers to its …
Darzalex to be trialled in combination with atezolizumab in multiple myeloma and solid tumours
March 22, 2016Research and Development Genentech, Genmab, Janssen, Roche, atezolizumab, clnical trials, multiple myeloma, phase ib, solid tumours, tumour
Phase Ib clinical studies are set to begin, which will evaluate Darzalex (daratumumab) in combination with atezolizumab in a solid …
Eisai cancer drug performs in sarcoma disease
February 26, 2015Sales and Marketing Cancer, Eisai, Halaven, eribulin, sarcoma, tumour
Eisai’s cancer drug Halaven met its primary endpoint and demonstrated overall survival benefit in two distinct solid tumour types in …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
